Literature DB >> 22981246

Survey finds that most meta-analysts do not attempt to collect individual patient data.

Stephanie A Kovalchik1.   

Abstract

OBJECTIVE: To characterize current efforts and outcomes of individual patient data (IPD) collection among meta-analysts of randomized controlled clinical trials. STUDY DESIGN AND
SETTING: Corresponding authors of meta-analyses of randomized controlled trials in general medicine with a binary endpoint were sent an e-mail survey inquiring about their efforts to obtain IPD. Descriptive statistics of each meta-analysis were extracted to evaluate their association with data seeking.
RESULTS: Only 22 (4.2%) of the sampled meta-analyses included IPD. Of the 360 authors surveyed, 256 (71%) reported not seeking IPD: 48% thought that the undertaking would be too difficult, 30% thought that it was not necessary for their main analysis, 25% did not have sufficient time or resources, and 22% never considered it. Seeking IPD was not significantly associated with any trial characteristic examined, including whether subgroup analyses were performed. Authors who sought IPD obtained a median of two data sets (interquartile range=0-5). Unsuccessful contact (43%), refusal without explanation (21%), and lost or inaccessible data (20%) were the most common reasons why trial data could not be obtained.
CONCLUSION: The infrequency of attempts made by meta-analysts to obtain participant data is an important contributor to the rarity of IPD meta-analyses. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22981246      PMCID: PMC3478473          DOI: 10.1016/j.jclinepi.2012.07.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  19 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

3.  Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head.

Authors:  Jesse A Berlin; Jill Santanna; Christopher H Schmid; Lynda A Szczech; Harold I Feldman
Journal:  Stat Med       Date:  2002-02-15       Impact factor: 2.373

4.  Meta-analysis of individual participant data: rationale, conduct, and reporting.

Authors:  Richard D Riley; Paul C Lambert; Ghada Abo-Zaid
Journal:  BMJ       Date:  2010-02-05

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 6.  A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners.

Authors:  D J Fisher; A J Copas; J F Tierney; M K B Parmar
Journal:  J Clin Epidemiol       Date:  2011-03-16       Impact factor: 6.437

7.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

Authors:  Christopher H Schmid; Paul C Stark; Jesse A Berlin; Paul Landais; Joseph Lau
Journal:  J Clin Epidemiol       Date:  2004-07       Impact factor: 6.437

8.  Meta-analysis of the literature or of individual patient data: is there a difference?

Authors:  L A Stewart; M K Parmar
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

9.  Whose data set is it anyway? Sharing raw data from randomized trials.

Authors:  Andrew J Vickers
Journal:  Trials       Date:  2006-05-16       Impact factor: 2.279

10.  Empirical study of data sharing by authors publishing in PLoS journals.

Authors:  Caroline J Savage; Andrew J Vickers
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more
  6 in total

1.  Practical Considerations and Challenges When Conducting an Individual Participant Data (IPD) Meta-Analysis.

Authors:  Sarah J Nevitt; Catrin Tudur Smith
Journal:  Methods Mol Biol       Date:  2022

2.  Aggregate-data estimation of an individual patient data linear random effects meta-analysis with a patient covariate-treatment interaction term.

Authors:  Stephanie A Kovalchik
Journal:  Biostatistics       Date:  2012-09-21       Impact factor: 5.899

Review 3.  A brief introduction of meta-analyses in clinical practice and research.

Authors:  Xiao-Meng Wang; Xi-Ru Zhang; Zhi-Hao Li; Wen-Fang Zhong; Pei Yang; Chen Mao
Journal:  J Gene Med       Date:  2021-03-25       Impact factor: 4.565

Review 4.  Comparing the Overall Result and Interaction in Aggregate Data Meta-Analysis and Individual Patient Data Meta-Analysis.

Authors:  Yafang Huang; Jinling Tang; Wilson Wai-San Tam; Chen Mao; Jinqiu Yuan; Mengyang Di; Zuyao Yang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Distribution and epidemiological characteristics of published individual patient data meta-analyses.

Authors:  Yafang Huang; Chen Mao; Jinqiu Yuan; Zuyao Yang; Mengyang Di; Wilson Wai-san Tam; Jinling Tang
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

6.  Strength in Numbers: The WWARN Case Study of Purpose-Driven Data Sharing.

Authors:  Georgina S Humphreys; Halidou Tinto; Karen I Barnes
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.